Assessing the Functional Significance of Novel and Rare Variants of the SLC26A4 Gene Found in Patients with Hearing Loss by Minigene Assay
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110732 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Valeriia Yu Danilchenko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. Hauptthemen laut MEDLINE: Sulfate Transporters, Hearing Loss, Sensorineural, Hearing Loss. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Budget Project of Institute of Cytology and Genetics SB RAS, the Russian Science Foundation, the Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
The SLC26A4 gene is one of the key genes involved in the etiology of hearing loss. It encodes pendrin, a transmembrane transporter protein functioning as a multifunctional anion exchanger. About 600 pathogenic SLC26A4 variants are known to cause either nonsyndromic recessive hearing loss (DFNB4) or Pendred syndrome (hearing loss and thyroid dysfunction). While most pathogenic variants occur in coding regions and disrupt pendrin structure or function, about 25% are thought to impair splicing. For many, pathogenicity has been assessed only in silico, with limited experimental confirmation. We identified several novel and rare SLC26A4 variants in patients with hearing loss from the Tyva and Altai Republics (Southern Siberia, Russia). Based on splicing predictions, six variants—intronic c.2034+1G>A, c.1545-168A>G, c.1708-125T>C, c.1708-18T>A, c.1804-31C>T, and exonic c.942A>G—were selected for analysis using a minigene assay. The results of in vitro analysis only partially matched in silico predictions: c.2034+1G>A caused aberrant splicing; c.1708-18T>A led to exon 16 skipping only in a small proportion of transcripts; the remaining variants showed no detectable splicing effect. These findings underscore the need for integrating in silico predictions with in vitro validation to accurately assess the functional impact of genetic variants, enabling their correct interpretation and reliable molecular diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.
- Novosibirsk State University, Novosibirsk 630090, Russia.
ORCID-Profile: Valeriia Yu Danilchenko, Marina V Zytzar, Konstantin E Orishchenko, Olga L Posukh
Förderung
- the Budget Project of Institute of Cytology and Genetics SB RAS
- the Russian Science Foundation
- the Ministry of Science and Higher Education of the Russian Federation
- Russian Science Foundation
- Budget Projects of Institute of Cytology and Genetics
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Danilchenko, V. Y., Panina, E. A., Zytzar, M. V., Orishchenko, K. E., & Posukh, O. L. (2025). Assessing the Functional Significance of Novel and Rare Variants of the SLC26A4 Gene Found in Patients with Hearing Loss by Minigene Assay. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110732
Vancouver
Danilchenko VY, Panina EA, Zytzar MV, Orishchenko KE, Posukh OL. Assessing the Functional Significance of Novel and Rare Variants of the SLC26A4 Gene Found in Patients with Hearing Loss by Minigene Assay. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110732
BibTeX
@article{Danilchenko2025,
author = {Danilchenko, Valeriia Yu and Panina, Ekaterina A and Zytzar, Marina V and Orishchenko, Konstantin E and Posukh, Olga L},
title = {Assessing the Functional Significance of Novel and Rare Variants of the SLC26A4 Gene Found in Patients with Hearing Loss by Minigene Assay},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110732}
}
EUVIMED